What is Tesamorelin?

Tesamorelin is a synthetic analogue of growth hormone-releasing hormone (GHRH), belonging to the class of peptide hormones. This bioactive compound consists of 44 amino acids and was originally developed by Theratechnologies Inc. in Canada. The peptide was first synthesized in the early 2000s as part of research into growth hormone deficiency and metabolic disorders.

Analysis and identity

Every batch is tested independently by an external laboratory. The certificate of analysis for this product is available on this page and states the method used, the purity determined and the date of analysis.

Available variants

Tesamorelin is available in 10mg and 20mg. The current price for each is shown with the product options on this page.

Storage and Handling

Store tesamorelin in lyophilized form at -20°C to -80°C, protected from light and moisture. Under these conditions, the peptide maintains its stability for at least 24 months. For reconstitution, sterile bacteriostatic water or physiological saline solution is recommended at a ratio of 1-2ml per 5mg of peptide. After reconstitution, the solution should be stored refrigerated at 2-8°C and used within 14 days for optimal activity. Avoid repeated freezing and thawing, as this can compromise molecular integrity. Always use sterile techniques when handling and ensure adequate personal protective equipment during laboratory work.

Research disclaimer

Tesamorelin supplied by Dutch Peptide Labs is intended solely for in vitro laboratory research and scientific purposes. This product is not intended for human or animal consumption, medicinal use, dietary application or therapeutic injection, and has not been approved by regulatory agencies such as the EMA or the FDA. Dutch Peptide Labs makes no claims as to effect, suitability or safety for any application in humans or animals. All use must take place under the supervision of qualified researchers. The seller accepts no liability for unauthorised or unlawful use of this product.